Net Cash Provided by (Used in) Financing Activities of BiomX Inc. from 30 Sep 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
BiomX Inc. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Sep 2018 to 31 Dec 2025.
  • BiomX Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $11,913,000, a 69% decline year-over-year.
  • BiomX Inc. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $13,189,000, a 66% decline from 2024.
  • BiomX Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $38,374,000, a 1224% increase from 2023.
  • BiomX Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $2,899,000, a 893% increase from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

BiomX Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $13,189,000 -$25,185,000 -66% 01 Jan 2025 31 Dec 2025 10-K 19 Feb 2026 2025 FY
2024 $38,374,000 +$35,475,000 +1224% 01 Jan 2024 31 Dec 2024 10-K 19 Feb 2026 2025 FY
2023 $2,899,000 +$2,607,000 +893% 01 Jan 2023 31 Dec 2023 10-K 25 Mar 2025 2024 FY
2022 $292,000 -$36,988,000 -99% 01 Jan 2022 31 Dec 2022 10-K 04 Apr 2024 2023 FY
2021 $37,280,000 +$37,146,000 +27721% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
2020 $134,000 -$61,420,000 -100% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
2019 $61,554,000 +$18,512,000 +43% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
2018 $43,042,000 01 Jan 2018 31 Dec 2018 10-K 26 Mar 2020 2019 FY

BiomX Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $11,913,000 -$27,062,000 -69% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q1 2024 $38,975,000 +$37,925,000 +3612% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q1 2023 $1,050,000 +$1,013,000 +2738% 01 Jan 2023 31 Mar 2023 10-Q 20 May 2024 2024 Q1
Q1 2022 $37,000 -$4,320,000 -99% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q1 2021 $4,357,000 +$4,326,000 +13955% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022 2022 Q1
Q1 2020 $31,000 -$1,769,000 -98% 01 Jan 2020 31 Mar 2020 10-Q 24 May 2021 2021 Q1
Q3 2019 $500,000 -$523,500 -2228% 01 Jul 2019 30 Sep 2019 10-Q 16 Oct 2019 2020 Q1
Q1 2019 $1,800,000 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q1
Q3 2018 $23,500 01 Jul 2018 30 Sep 2018 10-Q 16 Oct 2019 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.